Several of the substrates processed by ADAMs, especially by ADAM10 and ADAM17, have been implicated in the pathogenesis or progression of cancer [for reviews, see refs [4,5]], though some proteolytically inactive ADAMs may also play important roles in carcinogenesis (summarised in Table 1). The gene discussed is ADAM17; the disease is cancer.